Other bioinformatic studies analyzed and published in the Cancer Genome Atlas aiming to identify the prognostic role of biomarkers and possible targeted therapies for CRC concluded that MYC influences several tumor pathways and can be used as a predicting candidate for worse prognosis and targeted therapy.8 Here, MYC is linked to neoplasm.